Similar articles

• Proton pump inhibitors regulate metabolic profile and glycaemic indices in patients with type 2 diabetes mellitus: A rising dawn of a new therapeutic concept.

  Al-Bachaji IN, Al-Buhadiliy AK, Al-Kuraishy HM, Al-Gareeb AI. Al-Bachaji IN, et al. J Pak Med Assoc. 2019 Aug;69(Suppl 3)(8):S31-S35. J Pak Med Assoc. 2019. PMID: 31603873
• The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus.

  Han N, Oh M, Park SM, Kim YJ, Lee EJ, Kim TK, Kim TN, Kwon MJ, Kim MK, Lee SH, Rhee BD, Park JH. Han N, et al. Can J Diabetes. 2015 Feb;39(1):24-8. doi: 10.1016/j.jcjd.2013.10.008. Epub 2014 Oct 8. Can J Diabetes. 2015. PMID: 25305802
• Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus.

  Trang A, Bushman J, Halalau A. Trang A, et al. J Diabetes Res. 2021 Jul 29;2021:5578265. doi: 10.1155/2021/5578265. eCollection 2021. J Diabetes Res. 2021. PMID: 34368365 Free PMC article.
• Glycated Hemoglobin, Fasting, Two-hour Post-challenge and Postprandial Glycemia in the Diagnosis and Treatment of Diabetes Mellitus: Are We Giving Them the Right Interpretation and Use?

  Gómez-Pérez FJ. Gómez-Pérez FJ. Rev Invest Clin. 2015 Mar-Apr;67(2):76-9. Rev Invest Clin. 2015. PMID: 25938839 Review.
• Glycated haemoglobin (HbA1c) monitoring.

  Reynolds TM, Smellie WS, Twomey PJ. Reynolds TM, et al. BMJ. 2006 Sep 16;333(7568):586-8. doi: 10.1136/bmj.38947.627847.AE. BMJ. 2006. PMID: 16974013 Free PMC article. Review.